Provided by Tiger Trade Technology Pte. Ltd.

CRISPR Therapeutics AG

57.72
-1.6500-2.78%
Post-market: 57.62-0.1006-0.17%19:52 EDT
Volume:1.39M
Turnover:80.44M
Market Cap:5.58B
PE:-12.13
High:59.37
Open:58.22
Low:57.10
Close:59.37
52wk High:78.48
52wk Low:44.12
Shares:96.69M
Float Shares:93.17M
Volume Ratio:0.89
T/O Rate:1.49%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-4.7595
EPS(LYR):-6.4700
ROE:-26.09%
ROA:-14.20%
PB:3.20
PE(LYR):-8.92

Loading ...

Editas Medicine Announces First Quarter 2026 Results and Business Updates

GlobeNewswire
·
May 05

CRISPR Therapeutics Retains Buy Rating on Casgevy Momentum and 2026 Pipeline Catalysts Despite Price Target Trim to $83

TIPRANKS
·
May 05

CRISPR Therapeutics: Pipeline Expansion and In Vivo CAR-T Platform Support Buy Rating; $80 Price Target Reiterated

TIPRANKS
·
May 05

CRISPR Therapeutics Ag : Bofa Global Research Cuts Price Objective to $83.00 From $86.00

THOMSON REUTERS
·
May 05

Analysts’ Opinions Are Mixed on These Healthcare Stocks: GeneDx Holdings (WGS) and Crispr Therapeutics AG (CRSP)

TIPRANKS
·
May 05

Chardan Capital Remains a Buy on Crispr Therapeutics AG (CRSP)

TIPRANKS
·
May 05

CRISPR Therapeutics AG reports results for the quarter ended March 31 - Earnings Summary

Reuters
·
May 05

Switzerland's CRISPR Therapeutics Q1 net loss narrows

Reuters
·
May 05

CRISPR Therapeutics Q1 EPS $(1.28) Misses $(1.20) Estimate, Sales $1.458M Miss $2.700M Estimate

Benzinga Earnings
·
May 05

CRISPR Therapeutics Q1 net loss narrows to $122.9 million; revenue hits $43 million

Reuters
·
May 05

CRISPR Therapeutics Provides Business Update and Reports First Quarter 2026 Financial Results

GlobeNewswire
·
May 05

Press Release: Morningstar Reaches New Milestone in the CRSP Acquisition, Rebranding CRSP Market Indexes to Morningstar Indexes

Dow Jones
·
Apr 29

Intellia Therapeutics Reports Positive Phase 3 Trial Results for CRISPR-Based Gene Therapy

Deep News
·
Apr 27

Is CRISPR Therapeutics (CRSP) Share Price Aligning With Its Long Term Growth Story?

Simply Wall St.
·
Apr 24

Metagenomi Therapeutics, Inc. Announces Publication in Nature Structural & Molecular Biology Highlighting Proprietary Compact CRISPR Nuclease with Enhanced Genome Editing Efficiency

GlobeNewswire
·
Apr 16

Agilent Technologies (A) Valuation Check After CRISPR Patent Loss And BioTek Cytation 9 Launch

Simply Wall St.
·
Apr 15

Reaffirming Buy on CRISPR Therapeutics: Conference Engagement and Gene-Editing Leadership Support Attractive Risk‑Reward

TIPRANKS
·
Apr 14

This Nuclear Stock Had Its Best Day Ever. Cathie Wood's ARK Took the Moment to Sell. -- Barrons.com

Dow Jones
·
Apr 11

Is CRISPR Therapeutics (CRSP) Pricing Reflect Its Sharp Five‑Year Share Price Pullback

Simply Wall St.
·
Apr 09

CRISPR Therapeutics to Present at the 25th Annual Needham Virtual Healthcare Conference

GlobeNewswire
·
Apr 07